Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,893 | 620 | 99.8% |
| Education | $17.52 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,162 | 61 | $0 (2024) |
| ABBVIE INC. | $1,092 | 76 | $0 (2024) |
| PFIZER INC. | $953.73 | 53 | $0 (2024) |
| Amgen Inc. | $931.85 | 61 | $0 (2024) |
| Novo Nordisk Inc | $556.31 | 36 | $0 (2024) |
| Lilly USA, LLC | $513.67 | 30 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $504.14 | 33 | $0 (2024) |
| Allergan, Inc. | $464.97 | 41 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $385.91 | 27 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $382.52 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,514 | 82 | ABBVIE INC. ($308.67) |
| 2023 | $1,377 | 78 | ABBVIE INC. ($247.55) |
| 2022 | $1,555 | 93 | ABBVIE INC. ($195.53) |
| 2021 | $1,576 | 103 | AbbVie Inc. ($340.63) |
| 2020 | $1,290 | 86 | AstraZeneca Pharmaceuticals LP ($245.11) |
| 2019 | $907.86 | 63 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($175.33) |
| 2018 | $1,035 | 71 | AstraZeneca Pharmaceuticals LP ($164.10) |
| 2017 | $655.56 | 46 | AstraZeneca Pharmaceuticals LP ($114.28) |
All Payment Transactions
622 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: DIABETES | ||||||
| 09/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: Bone Health | ||||||
| 09/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Inflammation | ||||||
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: DIABETES | ||||||
| 08/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,396 | 1,952 | $243,075 | $141,833 |
| 2022 | 17 | 1,438 | 2,095 | $261,346 | $149,267 |
| 2021 | 15 | 1,445 | 2,149 | $267,877 | $155,180 |
| 2020 | 17 | 1,610 | 2,125 | $259,851 | $142,502 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 288 | 496 | $80,352 | $36,315 | 45.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 304 | 304 | $36,480 | $35,280 | 96.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 268 | 268 | $25,460 | $20,140 | 79.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 143 | 248 | $26,784 | $12,314 | 46.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 55 | 70 | $14,000 | $9,646 | 68.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 66 | 179 | $11,456 | $6,640 | 58.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 66 | $13,860 | $6,275 | 45.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 91 | $13,650 | $5,426 | 39.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 39 | 53 | $8,851 | $4,465 | 50.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $2,400 | $2,304 | 96.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 35 | $4,375 | $1,541 | 35.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 13 | $1,521 | $725.88 | 47.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 33 | 38 | $1,368 | $531.52 | 38.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 34 | $1,258 | $225.54 | 17.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 33 | 42 | $1,260 | $2.98 | 0.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 294 | 514 | $83,268 | $36,667 | 44.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 312 | 312 | $37,440 | $36,048 | 96.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 253 | 253 | $24,035 | $19,787 | 82.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 58 | 84 | $16,800 | $12,886 | 76.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 168 | 260 | $28,080 | $12,648 | 45.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 77 | 266 | $17,024 | $7,927 | 46.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 55 | 69 | $14,490 | $6,974 | 48.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 52 | 122 | $18,300 | $6,716 | 36.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 39 | 54 | $9,018 | $4,314 | 47.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $1,920 | $1,880 | 97.9% |
About Dr. Kyle Parish, MD
Dr. Kyle Parish, MD is a Family Medicine healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881622751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Parish, MD has received a total of $9,910 in payments from pharmaceutical and medical device companies, with $1,514 received in 2024. These payments were reported across 622 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($9,893).
As a Medicare-enrolled provider, Parish has provided services to 5,889 Medicare beneficiaries, totaling 8,321 services with total Medicare billing of $588,781. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Adolescent Medicine, Adult Medicine
- Location Paducah, KY
- Active Since 06/29/2006
- Last Updated 08/13/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881622751
Products in Payments
- FARXIGA (Drug) $981.36
- UBRELVY (Drug) $597.22
- Otezla (Drug) $563.30
- ELIQUIS (Drug) $538.71
- XIFAXAN (Drug) $497.48
- VRAYLAR (Drug) $489.83
- JARDIANCE (Drug) $337.77
- SOLIQUA 100/33 (Biological) $332.03
- NURTEC ODT (Drug) $269.45
- CHANTIX (Drug) $244.65
- TRINTELLIX (Drug) $241.12
- Ozempic (Drug) $235.17
- QULIPTA (Drug) $215.25
- ENTRESTO (Drug) $211.26
- VYVANSE (Drug) $202.80
- Azstarys (Drug) $189.71
- Aimovig (Biological) $161.33
- VIBERZI (Drug) $147.51
- Kerendia (Drug) $140.66
- Livalo (Drug) $136.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Paducah
James Turnbo, M.d. Psc, M.D. PSC
Family Medicine — Payments: $102,611
Dr. James Eickholz, Md, MD
Family Medicine — Payments: $15,716
Marissa Stewart-Jaynes, Md, MD
Family Medicine — Payments: $11,353
Mrs. Jennifer Nelson, Do, DO
Family Medicine — Payments: $9,999
Isaac Mittendorf, Md, MD
Family Medicine — Payments: $9,065
Mr. Kenneth Cook, Md, MD
Family Medicine — Payments: $7,920